IMCR vs MAR · rev $222.6M vs P/E 32, rev $13.72B
Immunocore Holdings Ltd (IMCR) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported MAR revenue for 2026-06-30 was $13.72B. Net income was $1.41B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
IMCR currently screens at market cap $1.45B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the IMCR and MAR stock pages for the full models.
Not investment advice.